Topics of Interest

Adapt. Adjust. Accept.

Highlights from Adaptive Devices Ask the Experts Videocast “My devices enable me to attain self-sufficiency and independence” – Victor Sheronas The recovery process from GBS, CIDP, MMN and other variants can be a long, even sometimes life-long process. When patients leave the hospital, they are transitioning into a space that in most cases is not…

Read More about Adapt. Adjust. Accept.

Navigating Insurance Reimbursement in CIDP: Commercial Insurance

Join us as we explore the reimbursement process as it relates to CIDP. These engaging, interactive sessions are tailored to those with either Commercial Insurance or Medicare. Register for your program today! “Navigating Insurance Reimbursement in CIDP: Commercial Insurance” is live on Thursday, August 19, 2021, at 12:15 PM EDT.  This session will explore the…

Read More about Navigating Insurance Reimbursement in CIDP: Commercial Insurance

Navigating Insurance Reimbursement in CIDP: Medicare

Join us as we explore the reimbursement process as it relates to CIDP. These engaging, interactive sessions are tailored to those with either Commercial Insurance or Medicare. Register for your program today! “Navigating Insurance Reimbursement in CIDP: Medicare”  is live on Thursday, August 19, 2021, at 3:15PM EDT.  this session we share how to navigate…

Read More about Navigating Insurance Reimbursement in CIDP: Medicare

Medicare B will cover an immunoglobulin therapy for patients with CIDP, starting July 18, 2021

A message from our industry partners at CSL Behring: We are pleased to share that effective July 18, Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, will be covered under Medicare Part B for maintenance therapy in adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).* Under the new coverage, Hizentra will be covered under the same benefit…

Read More about Medicare B will cover an immunoglobulin therapy for patients with CIDP, starting July 18, 2021